New miracle weapon against overweight: Graz tests innovative syringe!

New miracle weapon against overweight: Graz tests innovative syringe!

Graz, Österreich - History is written in Graz: The new generation of the weight loss injection, a further development of the weight from Ozempic, is currently being tested at the MedUni Graz. This innovative therapy has the potential to make weight reduction much more efficient by acting on two instead of just an appetite regulator. According to the experts, a possible weight loss of up to 25 percent is spoken of, which is hope for many overweight people. The initiative is an important step in the fight against the increasing epidemic of overweight, which, according to World Obesity Atlas, could affect around 51 percent of the world's population by 2035, such as reported.

Salicous obesity, also known as obesity, has devastating consequences for health-including diabetes, cardiovascular diseases and joint problems. Thomas Pieber, head of the Department of Endocrinology at the LKH University Hospital Graz, emphasizes that overweight not only increases the risk of many diseases, but also accelerates the aging process. The team of MedUni Graz, together with research partners at the University of Graz and MedUni Vienna, is involved in the search for healthy aging with regard to metabolism, such as Today. reported.

volunteers wanted for the study

In order to explore the optimal effect and dosage of the new syringe, healthy, non-childcare women and men between the ages of 18 and 64 are currently being sought with a body mass index (BMI) between 27 and 44.9 as a voluntary participant. For many in this age group, this could be a great opportunity to become part of a possibly groundbreaking project that could revolutionize the handling of overweight.